Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06153212

Regenerative Treatment of Peri-implantitis

Regenerative Treatment of Peri-implantitis: A Comparison of the Reinforced PTFE Mesh (RPM) and the Collagen Membrane in the Submerged Approach: a Randomized Controlled Clinical Trial

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the use of a new type of d-PTFE membrane called reinforced PTFE Mesh (RPM) with dental surgery. The regenerative outcomes of RPM membranes and collagen membrane for surgical reconstructive treatment of peri-implantitis (gum disease around implants) will be compared.

Detailed description

Peri-implantitis is an inflammatory response that leads to irreversible loss of implant supporting bone. This study will investigate the regenerative outcomes obtained with two membranes for surgical reconstructive treatment of peri-implantitis defects when the implant is submerged and primary wound closure is obtained. In one group the newly designed d-PTFE membrane with macropores, known as the RPM membrane will be utilized, which will be compared to the traditional collagen membrane used in the other group. The clinical, radiographic, and histologic outcomes for the regenerative treatment of peri-implantitis when utilizing the same bone graft in combination with either a collagen membrane or the RPM will be evaluated via a parallel-arm randomized controlled clinical trial. 32 patients with peri-implantitis will be recruited and randomized to receive peri-implantitis treatment with either a collagen membrane or an RPM membrane.

Conditions

Interventions

TypeNameDescription
PROCEDUREMembrane placement with bone graftingThe diseased dental implant will be cleaned and the bone defect will be filled with bone graft and covered by a membrane.

Timeline

Start date
2023-11-02
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2023-12-01
Last updated
2026-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06153212. Inclusion in this directory is not an endorsement.